Marketwatch, trending stocks
S&P 500 Wavers With Debt Ceiling in Focus
Walmart, Target, and Home Depot are set to report earnings this week
Tweet on stockmarket
Marketwatch:
Newmont (NEM): Stock in the gold miner rose 2.7% Oneok (OKE): Oneok stock fell 8.6%.
Sarepta Therapeutics (SRPT): The biotech stock surged more than 27%
Shake Shack (SHAK): stock stood at 8.6%
Activision Blizzard (ATVI): shares rose more than 1% #StockToWatch pic.twitter.com/tx6beZmwOF— The_Journalbiz (@the_journalbiz) May 15, 2023
Newmont (NEM): Stock in the gold miner rose 2.7% in afternoon trading after it agreed to buy Australia’s Newcrest Mining, concluding weeks of talks and marking a move into copper.
Oneok (OKE): The pipeline operator agreed to buy smaller rival Magellan Midstream Partners (MMP) for about $14 billion. Oneok stock fell 8.6%. The target company’s stock leaped nearly 14%.
Sarepta Therapeutics (SRPT): The biotech stock surged more than 27% on the news that the company’s experimental gene therapy to treat Duchenne muscular dystrophy was likely to receive Food and Drug Administration approval.
Shake Shack (SHAK): The Wall Street Journal reported that an activist shareholder is planning a proxy battle at the high-end burger chain. Shake Shack stock stood 8.6% in afternoon trading.
Monday.com (MNDY): Shares of the software company jumped 14% after it said it expects a full-year adjusted operating profit having earlier guided investors toward a loss.
Activision Blizzard (ATVI): The video game maker’s shares rose more than 1% after its planned merger with Microsoft obtained a European regulatory approval.
